Dr. Gearóid Tuohy

Applied Genetic Technologies Corporation (NASDAQ: AGTC; Florida, USA) announced the publication of positive preclinical data for X-linked retinitis pigmentosa

Applied Genetic Technologies Corporation Inc. (Nasdaq: AGTC) has announced the publication of positive preclinical data for X-linked retinitis pigmentosa.  The research study, entitled, “Dose Range Finding… Read More »Applied Genetic Technologies Corporation (NASDAQ: AGTC; Florida, USA) announced the publication of positive preclinical data for X-linked retinitis pigmentosa

Proof-of-concept study for oral synthetic 9 cis-retinyl provides visual rescue for late-onset autosomal dominant retinitis pigmentosa (adRP)

A collaborative research group with scientists working in Ireland, France, USA and Canada has reported the effects of single 7-day oral retinoid supplementation lasting “at… Read More »Proof-of-concept study for oral synthetic 9 cis-retinyl provides visual rescue for late-onset autosomal dominant retinitis pigmentosa (adRP)